RBC Capital Reiterates Outperform on Thermo Fisher Scientific, Maintains $767 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital has reiterated its 'Outperform' rating for Thermo Fisher Scientific, maintaining a price target of $767.
September 20, 2024 | 1:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its 'Outperform' rating for Thermo Fisher Scientific, maintaining a price target of $767. This suggests confidence in the company's future performance.
The reiteration of an 'Outperform' rating and a high price target by RBC Capital indicates positive sentiment and confidence in Thermo Fisher's future performance. This is likely to have a positive short-term impact on the stock price as investors may view this as a strong endorsement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100